RENALYTIX PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26 GBX | +1.96% |
|
-1.89% | +67.74% |
| Apr. 18 | Renalytix chief business officer to become president | AN |
| Apr. 18 | Renalytix Names Chief Business Officer as President | MT |
Chart calendar Renalytix Plc
7523a6b823bf62cda79339710b3cb02f.H3Wr_Zco7--v8sHwwNJ3DM0youaW1ng1Gv0Dv6LC3eQ.JwHjh64Qh4WeqLKEmZohaaBzkLagmCB3Xbgy59j3ta8yJ5jP_XnXg92jpg~eb2f7bb820f7114e56ed78856d8d55e6
Upcoming events on Renalytix Plc
Past events on Renalytix Plc
| 2024-04-22 10:00 am | Shareholders Meeting |
| 2024-03-13 | National Kidney Foundation Spring Clinical Meeting |
| 2024-02-15 02:00 am | Q2 2024 Earnings Release |
| 2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 2023-12-15 10:30 am | Annual General Meeting |
| 2023-11-14 08:30 am | Q1 2024 Earnings Call |
| 2023-11-14 02:00 am | Q1 2024 Earnings Release |
| 2023-09-28 08:30 am | Q4 2023 Earnings Call |
| 2023-09-28 02:00 am | Q4 2023 Earnings Release |
| 2023-06-26 02:30 pm | American Diabetes Association Scientific Conference - Dr. Girish Nadkarni |
| 2023-06-25 02:30 pm | American Diabetes Association Scientific Session - Kibum Kim |
| 2023-06-24 02:30 pm | American Diabetes Association Scientific Session - Dr. Joji Tokita |
| 2023-06-21 | American Association of Nurse Practitioner Conference |
| 2023-06-09 08:30 am | Q3 2023 Earnings Call |
| 2023-06-09 02:00 am | Q3 2023 Earnings Release |
| 2023-06-08 10:00 am | Shareholders Meeting |
| 2023-04-11 | National Kidney Foundation Clinical Spring Conference - Poster # 268 |
| 2023-04-11 | National Kidney Foundation Clinical Spring Conference - Poster #:278 |
| 2023-03-30 08:30 am | Q2 2023 Earnings Call |
| 2023-03-30 02:00 am | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | Giugno | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,03 - | 1,49 2,26 -34.01% | 2,97 2,95 0.8% | 3,40 3,59 -5.25% | 4,00 |
|
EBITDA Million USD | Released Forecast Spread | -5,41 -3,87 -39.8% | -9,83 -10,9 9.77% | -30,5 -29,1 -4.97% | -52,7 -53,2 0.94% | -41,8 -39,6 -5.74% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,54 -5,18 -26.16% | -11,1 -11,2 1.5% | -32,6 -31,3 -4.2% | -57,4 -52,8 -8.57% | -42,4 -42,3 -0.02% | -32,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -10,6 -11,4 6.93% | -35,8 -34,6 -3.53% | -49,6 -51,6 3.85% | -46,2 -45,0 -2.66% | 0,00 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -9,25 -10,5 11.75% | -31,0 -33,3 7.01% | -56,6 -53,7 -5.42% | -46,2 -42,4 -8.93% | -35,5 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -0,16 -0,17 7.88% | -0,43 -0,39 -10.26% | -0,78 0,00 - | -0,56 -0,45 -25% | 0,00 |
| Announcement Date | 03/09/19 | 27/10/20 | 21/10/21 | 31/10/22 | 28/09/23 | - |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,85 1,05 -19.52% | 0,81 2,02 -59.85% | 0,83 0,81 3.02% | 0,97 1,10 -11.91% | 1,19 1,28 -7.12% | 0,72 0,78 -7.57% | 0,52 0,82 -37.08% | 0,46 0,72 -35.8% | 0,71 0,77 -7.32% | 1,10 | 1,60 | 2,50 | 3,80 | 4,70 | |
|
EBITDA Million USD | Released Forecast Spread | -13,7 -12,7 -8.66% | -14,4 -12,5 -15.99% | -15,8 -13,4 -17.9% | -11,6 -10,2 -13.76% | -9,53 -10,3 7.5% | -10,8 -10,6 -1.76% | -9,95 -11,0 9.56% | -8,76 -8,70 -0.71% | -8,23 -8,80 6.51% | ||||||
|
EBIT Million USD | Released Forecast Spread | -13,9 -12,0 -15.37% | -14,6 -12,4 -17.1% | -17,2 -12,7 -36.1% | -11,7 -11,5 -2.48% | -9,66 -10,7 9.89% | -10,9 -9,68 -12.79% | -10,1 -10,9 7.32% | -8,89 -9,95 10.66% | -8,34 -8,80 5.28% | -8,40 | -8,20 | -7,70 | -7,10 | -6,50 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,3 -12,4 -23.44% | -14,7 -12,2 -20.18% | -9,51 -11,5 17.28% | -10,4 -11,6 9.93% | -12,1 -10,5 -15.44% | -11,7 -10,9 -7.11% | -10,2 -10,9 6.84% | ||||||||
|
Net income Million USD | Released Forecast Spread | -3,77 | -15,3 -12,2 -25.27% | -14,7 -12,8 -14.46% | -16,5 -13,6 -21.84% | -12,0 -9,85 -21.35% | -10,4 -10,7 2.38% | -12,1 -10,00 -21.11% | -11,7 -10,9 -7.05% | -10,2 -9,93 -2.3% | -8,49 -8,75 3.03% | -8,50 | -8,20 | -7,70 | -7,10 | -6,50 |
|
EPS USD | Released Forecast Spread | 0,00 | ||||||||||||||
| Announcement Date | 03/03/20 | 31/03/22 | 30/06/22 | 31/10/22 | 30/11/22 | 30/03/23 | 09/06/23 | 28/09/23 | 14/11/23 | 14/02/24 | - | - | - | - | - |
More events
Past sector events for Renalytix Plc
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RENX Stock
- Calendar Renalytix Plc
